Australia TGA ARTG recordActis DuoFix Hip Femoral Stem - Coated femoral stem prosthesis, modular
Australia TGA ARTG Registered Device · Johnson & Johnson Medical Pty Ltd t/a DePuy Synthes · Depuy (Ireland) · Class III · Started October 19, 2020
Good Name: Johnson & Johnson Medical Pty Ltd t/a DePuy Synthes - Actis DuoFix Hip Femoral Stem - Coated femoral stem prosthesis, modular
- Risk Class
- Class III
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- October 19, 2020
- Effective Date
- October 19, 2020
- Name
- Depuy (Ireland)
- Country
- Ireland
- Address
- Loughbeg Ringaskiddy, COUNTY CORK
The Actis DuoFix Hip Femoral Stem is intended for use in total hip arthroplasty to provide increased patient mobility and reduce pain by replacing the damaged hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components. The Actis DuoFix Hip Femoral Stem is intended for use in hemi-hip arthroplasty where there is evidence of a satisfactory natural acetabulum and sufficient femoral bone to seat and support the femoral stem.
Access comprehensive regulatory information for Actis DuoFix Hip Femoral Stem - Coated femoral stem prosthesis, modular in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is sponsored by Johnson & Johnson Medical Pty Ltd t/a DePuy Synthes, manufactured by Depuy (Ireland) in Ireland. The device registration started on October 19, 2020.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.